Is NCT03155893 results overdue?

Yes — results are overdue. Primary completion was 2017-10-27; the FDAAA-801 reporting deadline (2018-10-27) passed 2794 days ago and no results are posted on ClinicalTrials.gov.

A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants

NCT ID	NCT03155893 ↗
Sponsor	Janssen Research & Development, LLC (INDUSTRY)
Phase	PHASE1
Status	COMPLETED
Primary completion	2017-10-27 (ACTUAL)
Reporting deadline	2018-10-27 (completion + 365d)
Days overdue	2794
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `58a664d100c47514…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03155893. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.